Abiopharma

News list

Director Mayer Arie 🟢 acquired 34.9K shares of ORAMED PHARMACEUTICALS INC. (ORMP) Transaction Date: Dec 31, 2025 | Filing ID: 001275

Full text

News bot Jan. 5, 2026, 11:40 p.m.
🔍 Mayer Arie (Director)

Company: ORAMED PHARMACEUTICALS INC. (ORMP)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 34,900
Detailed Transactions and Holdings:
- Acquired 30,000 shares of Common Stock (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 163,109.00 | transaction_form_type: 4 | Footnotes: F1, F1
- Acquired 4,900 shares of Common Stock (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 168,009.00 | transaction_form_type: 4 | Footnotes: F2, F2
Footnotes:
- F1: Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.
- F2: Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.